| NCT06495749
| Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures | No drug interventions | Not Available | Not Available | not_yet_recruiting |
| NCT05483257
| Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma | No drug interventions | Not Available | Not Available | completed |
| NCT05287165
| Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms | No drug interventions | treatment | 0 | unknown_status |
| NCT05637567
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | | treatment | 2 | not_yet_recruiting |
| NCT06388967
| Pancreatic Cancer Detection Consortium | No drug interventions | Not Available | Not Available | recruiting |
| NCT03344172
| Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer | | treatment | 2 | terminated |
| NCT05479708
| ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma | No drug interventions | Not Available | Not Available | not_yet_recruiting |
| NCT04736043
| Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid | No drug interventions | Not Available | Not Available | recruiting |
| NCT04224402
| Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients. | No drug interventions | treatment | 2 | completed |
| NCT03977233
| Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | | treatment | 2 | recruiting |
| NCT05181605
| Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors | No drug interventions | treatment | 2 / 3 | recruiting |
| NCT06375928
| EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial) | No drug interventions | treatment | Not Available | not_yet_recruiting |
| NCT06287749
| French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) | | Not Available | Not Available | not_yet_recruiting |
| NCT06368063
| The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer | No drug interventions | treatment | 4 | recruiting |
| NCT03492671
| Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer | | treatment | 2 | recruiting |
| NCT05546411
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | | treatment | 2 | terminated |
| NCT03392571
| Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients | | treatment | 2 | withdrawn |
| NCT02243007
| Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | | treatment | 2 | terminated |
| NCT05624918
| A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma | | treatment | 2 | recruiting |
| NCT02115022
| EUS vs. MDCT in Pancreatic Malignancy | No drug interventions | Not Available | Not Available | completed |
| NCT03138720
| Pre-operative Treatment for Patients With Untreated Pancreatic Cancer | | treatment | 2 | active_not_recruiting |
| NCT01694589
| A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | | treatment | 0 | withdrawn |
| NCT05788744
| Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer | No drug interventions | basic_science | Not Available | recruiting |
| NCT05529940
| NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | No drug interventions | treatment | 3 | not_yet_recruiting |
| NCT04810910
| Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | No drug interventions | treatment | 1 | recruiting |
| NCT02775695
| Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer | | treatment | 2 | completed |
| NCT06363084
| A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer | | Not Available | Not Available | completed |
| NCT04737551
| Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study | No drug interventions | Not Available | Not Available | unknown_status |
| NCT01992705
| Borderline Pancreas Study: FOLFIRINOX +SBRT | | treatment | 0 | completed |
| NCT01298011
| Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer | | treatment | 2 | completed |
| NCT05181488
| Intraoperative Radiation Therapy for Resectable Pancreatic Cancer | No drug interventions | treatment | Not Available | active_not_recruiting |
| NCT06172036
| Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab | | treatment | 2 | not_yet_recruiting |
| NCT03822936
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | | treatment | 2 | unknown_status |
| NCT03435536
| Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer | No drug interventions | diagnostic | Not Available | completed |
| NCT02047513
| Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer | | treatment | 2 | completed |
| NCT05380557
| ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing | No drug interventions | Not Available | Not Available | terminated |
| NCT05209074
| Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | | treatment | 1 | recruiting |
| NCT02345460
| Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study | | treatment | 2 | terminated |
| NCT04472910
| GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma | No drug interventions | treatment | Not Available | active_not_recruiting |
| NCT03718650
| Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer | | diagnostic | 0 | withdrawn |
| NCT05679050
| Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer | No drug interventions | treatment | 2 | recruiting |
| NCT02318095
| Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer | | treatment | Not Available | completed |